Swiss chocolate manufacturer Barry Callebaut underwent a successful bond placement. In connection with the operation, Advestra advised Barry Callebaut after having already collaborated with the company on another bond issuance dating January 2025. Walder Wyss represented UBS, London Branch and the broader banking syndacate which led the transaction. The bonds The issuance, divided in two […]
Homburger advised Julius Baer Group on the issuance of USD 400 m CoCos. The context Julius Baer Group, a Swiss private bank specialised in wealth management successfully completed the issuance of USD 400 m of 7.5% Perpetual
Niederer Kraft Frey (NKF) advised EQT on the IPO of its portfolio company HBX Group. Moreover, the Swiss legal firm assisted EQT throughout the pre-IPO reorganisation of HBX’s corporate structure. The context Formerly known
Advestra advised Citigroup, UBS and Stifel Europe in connection with ther joint global coordination role in BioVersys’ IPO. The context BioVersys specialises in the identification, development and commercialization phases of novel antibacterial
Homburger advised Zürcher Kantonalbank (ZKB) as part of the joint lead management overseeing the successful issuance by Luzerner Kantonalbank (LUKB). ZKB acted as structuring advisor and joint-lead manager in connection with Luzerner Kantonalbank’s
Advestra advised Swiss chocolate manufacturer Barry Callebaut through successful CHF bond placement. The transaction The issuance, divided in two tranches, amounts to CHF 300 million in aggregate. The first tranche
Niederer Kraft Frey (NKF) advised Swiss company CGS, a full-service provider specialising in the disposal of landmines, Improvised Explosive Devices (IEDs) and other explosive hazards, on the sale of 2,532,055 shares in R&S Group (
Niederer Kraft Frey advised Société Générale and certain other financial institutions, all acting as joint lead managers in a 300 CHF bond issuance by Barry Callebaut, a Zurich-based global cocoa and chocolate product
Homburger advised BioVersys, a clinical-stage biopharmaceutical company domiciled in Basel, on all aspects of its Initial Public Offering (IPO). The Initial Public Offer The IPO was launched on SIX Swiss Exchange, comprising a primary
Homburger assisted AMAG Leasing, a Swiss car leasing services company, to successfully complete the issuance of CHF 100 m 1.625 per cent. Bonds. The fixed-income securities will eventually mature in 2028. AMAG Leasing’s is the subsidiary of
